These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33693620)

  • 1. T cell responses to Chlamydia.
    Helble JD; Starnbach MN
    Pathog Dis; 2021 Mar; 79(4):. PubMed ID: 33693620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of genital Chlamydia infection: insights from mouse models.
    Dockterman J; Coers J
    Pathog Dis; 2021 Mar; 79(4):. PubMed ID: 33538819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma Interferon Is Required for
    Helble JD; Gonzalez RJ; von Andrian UH; Starnbach MN
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses to Chlamydia trachomatis.
    Loomis WP; Starnbach MN
    Curr Opin Microbiol; 2002 Feb; 5(1):87-91. PubMed ID: 11834375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
    Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
    PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of Hysterectomized Mice with Chlamydia muridarum and Chlamydia trachomatis.
    Yang C; Whitmire WM; Sturdevant GL; Bock K; Moore I; Caldwell HD
    Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28461392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Predominant CD4
    Jordan SJ; Gupta K; Ogendi BMO; Bakshi RK; Kapil R; Press CG; Sabbaj S; Lee JY; Geisler WM
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28100498
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective immunity against Chlamydia trachomatis can engage both CD4+ and CD8+ T cells and bridge the respiratory and genital mucosae.
    Nogueira CV; Zhang X; Giovannone N; Sennott EL; Starnbach MN
    J Immunol; 2015 Mar; 194(5):2319-29. PubMed ID: 25637024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-Specific CD4
    Lin H; He C; Koprivsek JJ; Chen J; Zhou Z; Arulanandam B; Xu Z; Tang L; Zhong G
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.
    Picard MD; Bodmer JL; Gierahn TM; Lee A; Price J; Cohane K; Clemens V; DeVault VL; Gurok G; Kohberger R; Higgins DE; Siber GR; Flechtner JB; Geisler WM
    Clin Vaccine Immunol; 2015 Nov; 22(11):1206-18. PubMed ID: 26446421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis infection alters the development of memory CD8+ T cells.
    Loomis WP; Starnbach MN
    J Immunol; 2006 Sep; 177(6):4021-7. PubMed ID: 16951365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
    Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
    Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells.
    Johansson M; Lycke N
    Immunology; 2001 Feb; 102(2):199-208. PubMed ID: 11260325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin.
    Ibana JA; Myers L; Porretta C; Lewis M; Taylor SN; Martin DH; Quayle AJ
    BMC Immunol; 2012 Dec; 13():66. PubMed ID: 23216954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10.
    Coers J; Bernstein-Hanley I; Grotsky D; Parvanova I; Howard JC; Taylor GA; Dietrich WF; Starnbach MN
    J Immunol; 2008 May; 180(9):6237-45. PubMed ID: 18424746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen specific immune response in Chlamydia muridarum genital infection is dependent on murine microRNAs-155 and -182.
    Gupta R; Arkatkar T; Keck J; Koundinya GK; Castillo K; Hobel S; Chambers JP; Yu JJ; Guentzel MN; Aigner A; Christenson LK; Arulanandam BP
    Oncotarget; 2016 Oct; 7(40):64726-64742. PubMed ID: 27556515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory T cell responses in IRG-deficient mice prevent sustained Chlamydia trachomatis infections.
    Coers J; Gondek DC; Olive AJ; Rohlfing A; Taylor GA; Starnbach MN
    PLoS Pathog; 2011 Jun; 7(6):e1001346. PubMed ID: 21731484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection.
    Maxion HK; Liu W; Chang MH; Kelly KA
    Infect Immun; 2004 Nov; 72(11):6330-40. PubMed ID: 15501762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A
    Poston TB; Qu Y; Girardi J; O'Connell CM; Frazer LC; Russell AN; Wall M; Nagarajan UM; Darville T
    J Immunol; 2017 Oct; 199(8):2845-2854. PubMed ID: 28855311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.